National Institute Of Allergy
-
{
- All
- News
-
New HIV Vaccine Shows Promise In Human Trials
An experimental HIV vaccine was well-tolerated and generated immune responses against the deadly virus in healthy human adults, scientists say.
-
Scientists Identify New Genetic Immune Disorder
Scientists have identified a new genetic immune disorder that is characterised by increased susceptibility to a virus associated to a type of cancer.
-
Scientists Identify New Genetic Immune Disorder
Scientists have identified a new genetic immune disorder that is characterised by increased susceptibility to a virus associated to a type of cancer.
-
2 Experimental Ebola Vaccines Appear Safe Says United States Agency
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
-
New Drug Shields Monkeys from AIDS: Study
Scientists said on Wednesday a new drug tested on monkeys provided an astonishingly effective shield against an animal version of the AIDS virus, a major gain in the quest for an HIV vaccine.
-
Ebola Vaccines Trial Starts in Liberia
A large-scale human trial of two potential Ebola vaccines got under way in Liberia's capital Monday, part of a global effort to prevent a repeat of the epidemic that has now claimed nearly 9,000 lives in West Africa.
-
New HIV Vaccine Shows Promise In Human Trials
An experimental HIV vaccine was well-tolerated and generated immune responses against the deadly virus in healthy human adults, scientists say.
-
Scientists Identify New Genetic Immune Disorder
Scientists have identified a new genetic immune disorder that is characterised by increased susceptibility to a virus associated to a type of cancer.
-
Scientists Identify New Genetic Immune Disorder
Scientists have identified a new genetic immune disorder that is characterised by increased susceptibility to a virus associated to a type of cancer.
-
2 Experimental Ebola Vaccines Appear Safe Says United States Agency
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
-
New Drug Shields Monkeys from AIDS: Study
Scientists said on Wednesday a new drug tested on monkeys provided an astonishingly effective shield against an animal version of the AIDS virus, a major gain in the quest for an HIV vaccine.
-
Ebola Vaccines Trial Starts in Liberia
A large-scale human trial of two potential Ebola vaccines got under way in Liberia's capital Monday, part of a global effort to prevent a repeat of the epidemic that has now claimed nearly 9,000 lives in West Africa.
